Cite
HARVARD Citation
Wang-Lopez, Q. et al. (2015). Is It Important to Adapt Neoadjuvant Chemotherapy to the Visible Clinical Response? An Open Randomized Phase II Study Comparing Response-Guided and Standard Treatments in HER2-Negative Operable Breast Cancer. Oncologist. pp. 243-244. [Online].